Edition:
United Kingdom

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

3.09USD
19 Jul 2019
Change (% chg)

$0.03 (+0.98%)
Prev Close
$3.06
Open
$3.06
Day's High
$3.10
Day's Low
$2.95
Volume
29,101
Avg. Vol
57,554
52-wk High
$34.10
52-wk Low
$2.75

Select another date:

Tue, Jun 25 2019

FDA declines to approve Acer Therapeutics' rare genetic disorder treatment

Acer Therapeutics Inc said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture, sending its shares plunging as much as 78%.

UPDATE 2-FDA declines to approve Acer Therapeutics' rare genetic disorder treatment

June 25Acer Therapeutics Inc said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture, sending its shares plunging as much as 78%.

FDA declines to approve Acer Therapeutics' treatment for rare genetic disorder

June 25Acer Therapeutics Inc said on Tuesday its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture was declined approval from the U.S. Food and Drug Administration.

Select another date: